Enamel Surface and Elemental Changes Following In Vitro Bleaching: A SEM-EDS Approach
Abstract
Background and Objectives: Chairside bleaching can alter enamel morphology and mineral content. This in vitro study compared surface changes and elemental shifts after three in-office protocols using scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). Materials and Methods: Forty-two human premolars/molars were sectioned; matched halves served as control or received Opalescence Quick 45% carbamide peroxide (CP), Opalescence Boost 40% hydrogen peroxide (HP), or BlancOne Ultra+ 35% HP with light activation. Gels were applied per manufacturers’ instructions. SEM assessed topography (×500–×1100); EDS quantified atomic percent of O, Ca, P, C and trace elements. One-way ANOVA compared Ca and P between bleached groups (α = 0.05). Results: Controls showed compact surfaces with preserved Ca and P. After Quick, SEM revealed roughness, fissures and microcracks; Ca fell from 11.5 to 12.5 to 9.53–11.73 at% and P from 7.5 to 8.9 to 7.41–8.59 at%. Boost produced mild superficial restructuring and granular deposits with variable Ca 13.80–27.94 at% and P 7.32–14.65 at%. BlancOne Ultra+ caused diffuse erosion and loss of prismatic clarity with marked demineralization (Ca 1.42–7.85 at%, P 1.22–6.71 at%); C rose locally to 46.61 at%. Across bleached groups, Ca and P differed significantly (both p Boost > Quick. High-concentration, light-activated HP yielded the largest Ca/P losses. Clinically, neutral-pH, non-activated or chemically activated regimens and…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.